Development of a murine model of pulmonary chlorine exposure
Ended Awarded Last action
- Contract number
- HHSO10033001T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $1,047,136
Award facts
- Opportunity
-
- RFP15100SOL00004 Solicitation number
- BARDA Chem and RadNuc Animal Model Development Award Notice · Posted Dec 5, 2014
- Contract value 100% obligated
- $1,047,135.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$163,872 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $409,491 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $801,516 |
About this award
This is a federal contract award from the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit research organization. The award is for the development of a murine (mouse) model of pulmonary chlorine exposure, with a ceiling value of $1,047,135.50 and a period of performance ending on September 30, 2020. The contract is a cost-plus-fixed-fee type, without any set-aside designation. This award is associated with the Biological, Chemical, and Radiological/Nuclear (BARDA Chem and RadNuc) Animal Model 2015-2020 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which supports the development of animal models and medical countermeasures for ASPR. LBERI, a subsidiary of the Lovelace Biomedical Research Institute, has extensive experience in inhalation toxicology, infectious disease modeling, and medical countermeasure testing for federal agencies.
Quick answers
Who was awarded contract HHSO10033001T?
HHSO10033001T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 23, 2016.
How much is contract HHSO10033001T worth?
The government has obligated $1,047,136 on HHSO10033001T.
Is contract HHSO10033001T an order under another contract?
Yes. HHSO10033001T is a delivery order under HHSO100201500001I, an indefinite delivery contract, on BARDA Chem and RadNuc Animal Model 2015-2020.
Was contract HHSO10033001T competed?
The extent of competition for HHSO10033001T was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award